rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2022-214-227rsp-3155Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПоражение респираторного тракта при болезни Шёгрена, фокус на интерстициальное заболевание легкихRespiratory tract involvement in primary Sjögren’s syndrome, focus on interstitial lung diseasehttps://orcid.org/0000-0003-4188-3578ЧальцевБ. Д.ChaltsevB. D.

Чальцев  Богдан Дмитриевич

115522, Москва, Каширское шоссе, 34а

Bogdan D. Chaltsev

115522, Moscow, Kashirskoye Highway, 34A

bodya92@inbox.ruhttps://orcid.org/0000-0002-1425-8622ВасильевВ. И.VasilyevV. I.

107140, Москва, ул. Нижняя Красносельская, 4

Vladimir I. Vasilyev

107140, Moscow, Nizhnyaya Krasnoselskaya str., 4

АветисовИ. О.AvetisovI. O.

111033, Москва, ул. Волочаевская, 15, корп. 1

Ivan O. Avetisov

111033, Moscow, Volochaevskaya str., 15, korpus 1

https://orcid.org/0000-0001-8099-2107ТоргашинаА. В.TorgashinaA. V.

115522, Москва, Каширское шоссе, 34а

Anna V. Torgashina

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-2191-9361СоколЕ. В.SokolE. V.

115522, Москва, Каширское шоссе, 34а

Evgeniya V. Sokol

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0003-2314-1466ХванЮ. И.KhvanYu. I.

115522, Москва, Каширское шоссе, 34а

Yulia I. Khvan

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-3248-6426АнаньеваЛ. П.AnanyevaL. P.

115522, Москва, Каширское шоссе, 34а

Lidia P. Ananyeva

115522, Moscow, Kashirskoye Highway, 34A

ФГБНУ Научно-исследовательский институт ревматологии им. В.А. НасоновойРоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationРЕВМОЦЕНТР, ОООРоссияREVMOTSENTR, LLCRussian FederationКлинический госпиталь на Яузе, ОООРоссияKlinicheskiy gospital na Yauze, LLCRussian Federation202214052022602214227Copyright © Чальцев Б.Д., Васильев В.И., Аветисов И.О., Торгашина А.В., Сокол Е.В., Хван Ю.И., Ананьева Л.П., 20222022Чальцев Б.Д., Васильев В.И., Аветисов И.О., Торгашина А.В., Сокол Е.В., Хван Ю.И., Ананьева Л.П.Chaltsev B.D., Vasilyev V.I., Avetisov I.O., Torgashina A.V., Sokol E.V., Khvan Y.I., Ananyeva L.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3155

В статье приводится обзор литературы, посвященный современным представлениям о поражении респираторного тракта при болезни Шёгрена (БШ) с акцентом на интерстициальное заболевание легких (ИЗЛ). Обсуждаются также подходы к дифференциальной диагностике, лечению и скринингу БШ-ИЗЛ.

The article provides a literature review on the current understanding of respiratory tract damage in primary Sjögren’s syndrome (pSS) with an emphasis on interstitial lung disease (ILD), as well as approaches to the differential diagnosis, treatment, and screening of pSS-ILD.

болезнь Шёгренаинтерстициальное заболевание легкихлимфоцитарная интерстициальная пневмониялимфопролиферативные заболеванияритуксимабнинтеданибprimary Sjögren’s syndromeinterstitial lung diseaselymphocytic interstitial pneumonialymphoproliferative diseasesrituximabnintadanibИсследование не имело спонсорской поддержкиReferencesVivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren‘s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81-121. doi: 10.1016/j.clim.2019.04.009Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren‘s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81-121. doi: 10.1016/j.clim.2019.04.009Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72(2):162-165. doi: 10.1006/clin.1994.1123Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72(2):162-165. doi: 10.1006/clin.1994.1123Сафонова ТН, Васильев ВИ, Лихванцева ВГ. Синдром Шегрена: Руководство для врачей. М.:Издательство Московского государственного университета;2013.Safonova TN, Vasiliev VI, Likhvantseva VG. Sjögren‘s syndrome: A guide for physicians. Moscow:Izdatel’stvo Moskovskogo gosudarstvennogo universiteta;2013 (In Russ.).Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren’s syndrome. A clinical, pathological, and serological study of sixtytwo cases. Medicine (Baltimore). 1965;44:187-231.Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren’s syndrome. A clinical, pathological, and serological study of sixtytwo cases. Medicine (Baltimore). 1965;44:187-231.Свободина ОН, Гуревич ЛА, Васильев ВИ. Клинико-рентгенологическая и дифференциальная диагностика легочных изменений при болезни Шёгрена. Сборник резюме 2-го Всесоюзного конгресса по болезням органов дыхания в Челябинске. М.;1991:175.Svobodina ON, Gurevich LA, Vasiliev VI. Clinical, X-ray and differential diagnosis of pulmonary changes in Sjögren’s disease. Sbornik rezyume 2-go Vsesoyuznogo kongressa po boleznyam organov dykhaniya v Chelyabinske. Moscow;1991:175 (In Russ.).Свободина ОН, Гуревич ЛА, Васильев ВИ. Клиникорентгенологическая диагностика поражения органов дыхания при болезни Шёгрена. Тезисы докладов IV Всесоюзного съезда ревматологов. Минск;1991:25.Svobodina ON, Gurevich LA, Vasiliev VI. Clinical and radiological diagnosis of respiratory lesions in Sjögren’s disease. Tezisy dokladov IV Vsesoyuznogo sjezda revmatologov. Minsk;1991:25 (In Russ.).Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K. Pulmonary lesions associated with Sjögren’s syndrome: Radiographic and CT findings. Br J Radiol. 2003;76(912):880-884. doi: 10.1259/bjr/18937619Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K. Pulmonary lesions associated with Sjögren’s syndrome: Radiographic and CT findings. Br J Radiol. 2003;76(912):880-884. doi: 10.1259/bjr/18937619Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Lung complications of Sjogren syndrome. Eur Respir Rev. 2020;29(157):200021. doi: 10.1183/16000617.0021-2020Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Lung complications of Sjogren syndrome. Eur Respir Rev. 2020;29(157):200021. doi: 10.1183/16000617.0021-2020Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JD, Müller NL. Follicular bronchiolitis: Thin-section CT and histologic findings. Radiology. 1999;212(3):637-642. doi: 10.1148/radiology.212.3.r99se04637Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JD, Müller NL. Follicular bronchiolitis: Thin-section CT and histologic findings. Radiology. 1999;212(3):637-642. doi: 10.1148/radiology.212.3.r99se04637Flament T, Bigot A, Chaigne B, Henique H, Diot E, MarchandAdam S. Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev. 2016;25(140):110-123. doi: 10.1183/16000617.0011-2016Flament T, Bigot A, Chaigne B, Henique H, Diot E, MarchandAdam S. Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev. 2016;25(140):110-123. doi: 10.1183/16000617.0011-2016Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren’s syndrome: A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-638. doi: 10.1164/rccm.200403-417OCIto I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren’s syndrome: A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-638. doi: 10.1164/rccm.200403-417OCShi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, et al. Pulmonary manifestations of Sjögren’s syndrome. Respiration. 2009;78(4):377-386. doi: 10.1159/000214841Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, et al. Pulmonary manifestations of Sjögren’s syndrome. Respiration. 2009;78(4):377-386. doi: 10.1159/000214841Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol. 2004;22(4):485-494.Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol. 2004;22(4):485-494.Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61-64. doi: 10.1136/ard.58.1.61Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61-64. doi: 10.1136/ard.58.1.61Natalini JG, Johr C, Kreider M. Pulmonary Involvement in Sjögren Syndrome. Clin Chest Med. 2019;40(3):531-544. doi: 10.1016/j.ccm.2019.05.002Natalini JG, Johr C, Kreider M. Pulmonary Involvement in Sjögren Syndrome. Clin Chest Med. 2019;40(3):531-544. doi: 10.1016/j.ccm.2019.05.002Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjögren’s syndrome: Underlying immunological mechanisms, clinical presentation, and management. Front Immunol. 2019;10:1327. doi: 10.3389/fimmu.2019.01327Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjögren’s syndrome: Underlying immunological mechanisms, clinical presentation, and management. Front Immunol. 2019;10:1327. doi: 10.3389/fimmu.2019.01327Kakugawa T, Sakamoto N, Ishimoto H, Shimizu T, Nakamura H, Nawata A, et al. Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren’s syndrome. Respir Med. 2018;137:95-102. doi: 10.1016/j.rmed.2018.02.023Kakugawa T, Sakamoto N, Ishimoto H, Shimizu T, Nakamura H, Nawata A, et al. Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren’s syndrome. Respir Med. 2018;137:95-102. doi: 10.1016/j.rmed.2018.02.023Yachoui R, Leon C, Sitwala K, Kreidy M. Pulmonary MALT lymphoma in patients with Sjögren’s Syndrome. Clin Med Res. 2017;15(1-2):6-12. doi: 10.3121/cmr.2017.1341Yachoui R, Leon C, Sitwala K, Kreidy M. Pulmonary MALT lymphoma in patients with Sjögren’s Syndrome. Clin Med Res. 2017;15(1-2):6-12. doi: 10.3121/cmr.2017.1341Wise LM, Arkfeld DG. A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: A case-based review. Clin Rheumatol. 2020;39(4):1357-1362. doi: 10.1007/s10067-019-04886-7Wise LM, Arkfeld DG. A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: A case-based review. Clin Rheumatol. 2020;39(4):1357-1362. doi: 10.1007/s10067-019-04886-7Васильев ВИ, Пробатова НА, Тупицын НН, Варламова ЕЮ, Логвиненко ОА, Ковригина АМ, и др. Лимфопролиферативные заболевания при болезни Шегрена. Онкогематология. 2007;2(3):16-26.Vasiljev VI, Probatova NA, Tupitsyn NN, Varlamova EYu, Logvinenko OA, Kovrigina AM, et al. Lymphoproliferative diseases in primary Sjogren’s syndrome. Oncohematology. 2007;2(3):16-26 (In Russ.).Gorodetskiy VR, Probatova NA, Vasilyev VI. Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2020;23(4):540-548. doi: 10.1111/1756-185X.13800Gorodetskiy VR, Probatova NA, Vasilyev VI. Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2020;23(4):540-548. doi: 10.1111/1756-185X.13800Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis. 2014;73(8):1537-1540. doi: 10.1136/annrheumdis-2013-204634Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis. 2014;73(8):1537-1540. doi: 10.1136/annrheumdis-2013-204634Carubbi F, Alunno A, Cipriani P, Bartoloni E, Baldini C, Quartuccio L, et al. A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome. Lupus. 2015;24(3):315-320. doi: 10.1177/0961203314554251Carubbi F, Alunno A, Cipriani P, Bartoloni E, Baldini C, Quartuccio L, et al. A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome. Lupus. 2015;24(3):315-320. doi: 10.1177/0961203314554251Quartuccio L, Baldini C, Priori R, Bartoloni E, Carubbi F, Alunno A, et al.; GRISS Group. Cryoglobulinemia in Sjögren syndrome: A disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosaassociated lymphoid tissue. J Rheumatol. 2017;44(8):1179-1183. doi: 10.3899/jrheum.161465Quartuccio L, Baldini C, Priori R, Bartoloni E, Carubbi F, Alunno A, et al.; GRISS Group. Cryoglobulinemia in Sjögren syndrome: A disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosaassociated lymphoid tissue. J Rheumatol. 2017;44(8):1179-1183. doi: 10.3899/jrheum.161465Sambataro G, Ferro F, Orlandi M, Sambataro D, Torrisi SE, Quartuccio L, et al. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj°gren’s syndrome: A systematic review from the Italian Society of Rheumatology. Autoimmun Rev. 2020;19(2):102447. doi: 10.1016/j.autrev.2019.102447Sambataro G, Ferro F, Orlandi M, Sambataro D, Torrisi SE, Quartuccio L, et al. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj°gren’s syndrome: A systematic review from the Italian Society of Rheumatology. Autoimmun Rev. 2020;19(2):102447. doi: 10.1016/j.autrev.2019.102447Hida A, Imaizumi M, Sera N, Akahoshi M, Soda M, Maeda R, et al. Association of human T lymphotropic virus type I with Sjogren syndrome. Ann Rheum Dis. 2010;69(11):2056-2057. doi: 10.1136/ard.2010.128736Hida A, Imaizumi M, Sera N, Akahoshi M, Soda M, Maeda R, et al. Association of human T lymphotropic virus type I with Sjogren syndrome. Ann Rheum Dis. 2010;69(11):2056-2057. doi: 10.1136/ard.2010.128736Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A. Information provision for stroke survivors and their carers. Cochrane Database Syst Rev. 2021;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A. Information provision for stroke survivors and their carers. Cochrane Database Syst Rev. 2021;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4Yamashiro T, Kamiya H, Miyara T, Gibo S, Ogawa K, Akamine T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: Presence of interstitial pneumonia. Acad Radiol. 2012;19(8):952-957. doi: 10.1016/j.acra.2012.03.020Yamashiro T, Kamiya H, Miyara T, Gibo S, Ogawa K, Akamine T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: Presence of interstitial pneumonia. Acad Radiol. 2012;19(8):952-957. doi: 10.1016/j.acra.2012.03.020Okada F, Ando Y, Yoshitake S, Yotsumoto S, Matsumoto S, Wakisaka M, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology. 2006;240(2):559-564. doi: 10.1148/radiol.2402050886Okada F, Ando Y, Yoshitake S, Yotsumoto S, Matsumoto S, Wakisaka M, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology. 2006;240(2):559-564. doi: 10.1148/radiol.2402050886Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest. 2004;125(4):1239-1247. doi: 10.1378/chest.125.4.1239Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest. 2004;125(4):1239-1247. doi: 10.1378/chest.125.4.1239Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjogren’s syndrome 1976–2005 and associated interstitial lung disease: A population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569. doi: 10.1136/bmjopen-2013-003569Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjogren’s syndrome 1976–2005 and associated interstitial lung disease: A population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569. doi: 10.1136/bmjopen-2013-003569Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, et al. Interstitial lung disease in Sjögren’s syndrome: A clinical review. Clin Exp Rheumatol. 2020;38 Suppl 126(4):291-300.Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, et al. Interstitial lung disease in Sjögren’s syndrome: A clinical review. Clin Exp Rheumatol. 2020;38 Suppl 126(4):291-300.Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren’s syndrome: A cross sectional and longitudinal study. Thorax. 1991;46(3):180-183. doi: 10.1136/thx.46.3.180Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren’s syndrome: A cross sectional and longitudinal study. Thorax. 1991;46(3):180-183. doi: 10.1136/thx.46.3.180Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, et al. Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement. Clin Rheumatol. 2017;36(6):1261-1268. doi: 10.1007/s10067-017-3601-1Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, et al. Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement. Clin Rheumatol. 2017;36(6):1261-1268. doi: 10.1007/s10067-017-3601-1Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, et al. Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev. 2017;16(1):48-54. doi: 10.1016/j.autrev.2016.09.017Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, et al. Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev. 2017;16(1):48-54. doi: 10.1016/j.autrev.2016.09.017Ter Borg EJ, Kelder JC. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren’s syndrome: A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort. Rheumatol Int. 2017;37(7):1153-1158. doi: 10.1007/s00296-017-3715-4Ter Borg EJ, Kelder JC. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren’s syndrome: A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort. Rheumatol Int. 2017;37(7):1153-1158. doi: 10.1007/s00296-017-3715-4Wang Y, Hou Z, Qiu M, Ye Q. Risk factors for primary Sjögren syndrome-associated interstitial lung disease. J Thorac Dis. 2018;10(4):2108-2117. doi: 10.21037/jtd.2018.03.120Wang Y, Hou Z, Qiu M, Ye Q. Risk factors for primary Sjögren syndrome-associated interstitial lung disease. J Thorac Dis. 2018;10(4):2108-2117. doi: 10.21037/jtd.2018.03.120Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, et al. Prognostic factors in interstitial lung disease associated with primary Sjögren’s syndrome: A retrospective analysis of 33 pathologically-proven cases. PLoS One. 2013;8(9):e73774. doi: 10.1371/journal.pone.0073774Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, et al. Prognostic factors in interstitial lung disease associated with primary Sjögren’s syndrome: A retrospective analysis of 33 pathologically-proven cases. PLoS One. 2013;8(9):e73774. doi: 10.1371/journal.pone.0073774Gao H, Zou YD, Zhang XW, He J, Zhang J, Sun Y, et al. Interstitial lung disease in non-sicca onset primary Sjögren’s syndrome: A large-scale case-control study. Int J Rheum Dis. 2018;21(7):1423-1429. doi: 10.1111/1756-185X.13334Gao H, Zou YD, Zhang XW, He J, Zhang J, Sun Y, et al. Interstitial lung disease in non-sicca onset primary Sjögren’s syndrome: A large-scale case-control study. Int J Rheum Dis. 2018;21(7):1423-1429. doi: 10.1111/1756-185X.13334Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerdà D, Castellví I, Díaz Torné C, et al. Sjögren’s syndrome-associated interstitial lung disease: A multicenter study. Reumatol Clin. 2016;12(4):201-205. doi: 10.1016/j.reuma.2015.09.003Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerdà D, Castellví I, Díaz Torné C, et al. Sjögren’s syndrome-associated interstitial lung disease: A multicenter study. Reumatol Clin. 2016;12(4):201-205. doi: 10.1016/j.reuma.2015.09.003Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren’s syndrome. Clin Chest Med. 1998;19(4):687-viii. doi: 10.1016/s0272-5231(05)70110-6Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren’s syndrome. Clin Chest Med. 1998;19(4):687-viii. doi: 10.1016/s0272-5231(05)70110-6García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, CalvoAlen J, Cervera R, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280. doi: 10.1097/00005792200207000-00003García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, CalvoAlen J, Cervera R, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280. doi: 10.1097/00005792200207000-00003Yazisiz V, Ozbudak IH, Nizam I, Erbasan F, Avci AB, Ozbudak O, et al. A case of primary Sjögren’s syndrome with pulmonary-limited Wegener’s granulomatosis. Rheumatol Int. 2010;30(9):1235-1238. doi: 10.1007/s00296-009-1045-xYazisiz V, Ozbudak IH, Nizam I, Erbasan F, Avci AB, Ozbudak O, et al. A case of primary Sjögren’s syndrome with pulmonary-limited Wegener’s granulomatosis. Rheumatol Int. 2010;30(9):1235-1238. doi: 10.1007/s00296-009-1045-xDavidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2000;59(9):709-712. doi: 10.1136/ard.59.9.709Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2000;59(9):709-712. doi: 10.1136/ard.59.9.709Gao H, Zhang XW, He J, Zhang J, An Y, Sun Y, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A casecontrol study. Medicine (Baltimore). 2018;97(24):e11003. doi: 10.1097/MD.0000000000011003Gao H, Zhang XW, He J, Zhang J, An Y, Sun Y, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A casecontrol study. Medicine (Baltimore). 2018;97(24):e11003. doi: 10.1097/MD.0000000000011003Li X, Xu B, Ma Y, Li X, Cheng Q, Wang X, et al. Clinical and laboratory profiles of primary Sjogren’s syndrome in a Chinese population: A retrospective analysis of 315 patients. Int J Rheum Dis. 2015;18(4):439-446. doi: 10.1111/1756-185X.12583Li X, Xu B, Ma Y, Li X, Cheng Q, Wang X, et al. Clinical and laboratory profiles of primary Sjogren’s syndrome in a Chinese population: A retrospective analysis of 315 patients. Int J Rheum Dis. 2015;18(4):439-446. doi: 10.1111/1756-185X.12583Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006;130(5):1489-1495. doi: 10.1378/chest.130.5.1489Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006;130(5):1489-1495. doi: 10.1378/chest.130.5.1489Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren’s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981-2988. doi: 10.1007/s10067-018-4289-6Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren’s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981-2988. doi: 10.1007/s10067-018-4289-6Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sjögren’s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020;39(5):1561-1568. doi: 10.1007/s10067-01904906-6Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sjögren’s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020;39(5):1561-1568. doi: 10.1007/s10067-01904906-6Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al.; GEMESS Study Group. Primary Sjögren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210-219. doi: 10.1097/MD.0b013e318181e6afRamos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al.; GEMESS Study Group. Primary Sjögren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210-219. doi: 10.1097/MD.0b013e318181e6afLee AS, Scofield RH, Hammitt KM, Gupta N, Thomas DE, Moua T, et al.; Consensus Expert Panel (CEP) Members. Consensus guidelines for evaluation and management of pulmonary disease in Sjögren’s. Chest. 2021;159(2):683-698. doi: 10.1016/j.chest.2020.10.011Lee AS, Scofield RH, Hammitt KM, Gupta N, Thomas DE, Moua T, et al.; Consensus Expert Panel (CEP) Members. Consensus guidelines for evaluation and management of pulmonary disease in Sjögren’s. Chest. 2021;159(2):683-698. doi: 10.1016/j.chest.2020.10.011He C, Chen Z, Liu S, Chen H, Zhang F. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren’s syndrome: A systematic review and meta-analysis. Int J Rheum Dis. 2020;23(8):1009-1018. doi: 10.1111/1756-185X.13881He C, Chen Z, Liu S, Chen H, Zhang F. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren’s syndrome: A systematic review and meta-analysis. Int J Rheum Dis. 2020;23(8):1009-1018. doi: 10.1111/1756-185X.13881Sogkas G, Hirsch S, Olsson KM, Hinrichs JB, Thiele T, Seeliger T, et al. Lung involvement in primary Sjögren’s syndrome – An underdiagnosed entity. Front Med (Lausanne). 2020;7:332. doi: 10.3389/fmed.2020.00332Sogkas G, Hirsch S, Olsson KM, Hinrichs JB, Thiele T, Seeliger T, et al. Lung involvement in primary Sjögren’s syndrome – An underdiagnosed entity. Front Med (Lausanne). 2020;7:332. doi: 10.3389/fmed.2020.00332Chen MH, Chou HP, Lai CC, Chen YD, Chen MH, Lin HY, et al. Lung involvement in primary Sjögren’s syndrome: Correlation between high-resolution computed tomography score and mortality. J Chin Med Assoc. 2014;77(2):75-82. doi: 10.1016/j.jcma.2013.11.001Chen MH, Chou HP, Lai CC, Chen YD, Chen MH, Lin HY, et al. Lung involvement in primary Sjögren’s syndrome: Correlation between high-resolution computed tomography score and mortality. J Chin Med Assoc. 2014;77(2):75-82. doi: 10.1016/j.jcma.2013.11.001Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, et al. High-resolution CT imaging of the lung for patients with primary Sjogren’s syndrome. Eur J Radiol. 2004;52(2):137-143. doi: 10.1016/j.ejrad.2004.01.006Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, et al. High-resolution CT imaging of the lung for patients with primary Sjogren’s syndrome. Eur J Radiol. 2004;52(2):137-143. doi: 10.1016/j.ejrad.2004.01.006Franquet T, Giménez A, Monill JM, Díaz C, Geli C. Primary Sjögren’s syndrome and associated lung disease: CT findings in 50 patients. Am J Roentgenol. 1997;169(3):655-658. doi: 10.2214/ajr.169.3.9275871Franquet T, Giménez A, Monill JM, Díaz C, Geli C. Primary Sjögren’s syndrome and associated lung disease: CT findings in 50 patients. Am J Roentgenol. 1997;169(3):655-658. doi: 10.2214/ajr.169.3.9275871Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973;57(3):809-843. doi: 10.1016/s0025-7125(16)32278-7Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973;57(3):809-843. doi: 10.1016/s0025-7125(16)32278-7Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, et al.; EULAR Sjögren Syndrome Task Force. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015;54(12):2230-2238. doi: 10.1093/rheumatology/kev200Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, et al.; EULAR Sjögren Syndrome Task Force. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015;54(12):2230-2238. doi: 10.1093/rheumatology/kev200Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. Am J Roentgenol. 1999;173(1):71-74. doi: 10.2214/ajr.173.1.10397102Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. Am J Roentgenol. 1999;173(1):71-74. doi: 10.2214/ajr.173.1.10397102Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: A narrative review. Chest. 2002;122(6):2150-2164. doi: 10.1378/chest.122.6.2150Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: A narrative review. Chest. 2002;122(6):2150-2164. doi: 10.1378/chest.122.6.2150Johkoh T, Müller NL, Pickford HA, Hartman TE, Ichikado K, Akira M, et al. Lymphocytic interstitial pneumonia: Thin-section CT findings in 22 patients. Radiology. 1999;212(2):567-572. doi: 10.1148/radiology.212.2.r99au05567Johkoh T, Müller NL, Pickford HA, Hartman TE, Ichikado K, Akira M, et al. Lymphocytic interstitial pneumonia: Thin-section CT findings in 22 patients. Radiology. 1999;212(2):567-572. doi: 10.1148/radiology.212.2.r99au05567Carignan S, Staples CA, Müller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology. 1995;197(1):53-58. doi: 10.1148/radiology.197.1.7568853Carignan S, Staples CA, Müller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology. 1995;197(1):53-58. doi: 10.1148/radiology.197.1.7568853Watanabe Y, Koyama S, Miwa C, Okuda S, Kanai Y, Tetsuka K, et al. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjögren’s syndrome showing only the LIP pattern radiologically. Intern Med. 2012;51(5):491-495. doi: 10.2169/internalmedicine.51.6242Watanabe Y, Koyama S, Miwa C, Okuda S, Kanai Y, Tetsuka K, et al. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjögren’s syndrome showing only the LIP pattern radiologically. Intern Med. 2012;51(5):491-495. doi: 10.2169/internalmedicine.51.6242Rajagopala S, Singh N, Gupta K, Gupta D. Pulmonary amyloidosis in Sjogren’s syndrome: A case report and systematic review of the literature. Respirology. 2010;15(5):860-866. doi: 10.1111/j.1440-1843.2010.01772.xRajagopala S, Singh N, Gupta K, Gupta D. Pulmonary amyloidosis in Sjogren’s syndrome: A case report and systematic review of the literature. Respirology. 2010;15(5):860-866. doi: 10.1111/j.1440-1843.2010.01772.xJeong YJ, Lee KS, Chung MP, Han J, Chung MJ, Kim KI, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: Thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28(6):776-781. doi: 10.1097/00004728-200411000-00008Jeong YJ, Lee KS, Chung MP, Han J, Chung MJ, Kim KI, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: Thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28(6):776-781. doi: 10.1097/00004728-200411000-00008Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren’s syndrome. Autoimmun Rev. 2004;3(3):175-182. doi: 10.1016/S1568-9972(03)00102-2Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren’s syndrome. Autoimmun Rev. 2004;3(3):175-182. doi: 10.1016/S1568-9972(03)00102-2Nicholson AG, Wotherspoon AC, Diss TC, Hansell DM, Du Bois R, Sheppard MN, et al. Reactive pulmonary lymphoid disorders. Histopathology. 1995;26(5):405-412. doi: 10.1111/j.1365-2559.1995.tb00247.xNicholson AG, Wotherspoon AC, Diss TC, Hansell DM, Du Bois R, Sheppard MN, et al. Reactive pulmonary lymphoid disorders. Histopathology. 1995;26(5):405-412. doi: 10.1111/j.1365-2559.1995.tb00247.xTirelli C, Zanframundo G, Valentini A, Bortolotto C, Dore R, Oggionni T, et al. CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis. Radiol Case Rep. 2020;15(11):23312334. doi: 10.1016/j.radcr.2020.08.012Tirelli C, Zanframundo G, Valentini A, Bortolotto C, Dore R, Oggionni T, et al. CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis. Radiol Case Rep. 2020;15(11):23312334. doi: 10.1016/j.radcr.2020.08.012Heraganahally S, Digges M, Haygarth M, Liyanaarachchi K, Kalro A, Mehra S. Pulmonary AL-amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren’s syndrome. Respir Med Case Rep. 2018;26:94-97. doi: 10.1016/j.rmcr.2018.11.015Heraganahally S, Digges M, Haygarth M, Liyanaarachchi K, Kalro A, Mehra S. Pulmonary AL-amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren’s syndrome. Respir Med Case Rep. 2018;26:94-97. doi: 10.1016/j.rmcr.2018.11.015Федоров АБ, Кучма ЮМ. Болезнь отложения легких цепей (болезнь Randall). Клиническая онкогематология. 2009;2(4):362-366.Fedorov AB, Kouchma YuM. Light chain deposition disease (Randall disease). Clinical Oncohematology. 2009;2(4):362-366 (In Russ.).Kijner CH, Yousem SA. Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature. Am J Surg Pathol. 1988;12(5):405-413. doi: 10.1097/00000478-198805000-00009Kijner CH, Yousem SA. Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature. Am J Surg Pathol. 1988;12(5):405-413. doi: 10.1097/00000478-198805000-00009Khoor A, Myers JL, Tazelaar HD, Kurtin PJ. Amyloid-like pulmonary nodules, including localized light-chain deposition: Clinicopathologic analysis of three cases. Am J Clin Pathol. 2004;121(2):200-204. doi: 10.1309/3GEC-PW24-02F6-V8EKKhoor A, Myers JL, Tazelaar HD, Kurtin PJ. Amyloid-like pulmonary nodules, including localized light-chain deposition: Clinicopathologic analysis of three cases. Am J Clin Pathol. 2004;121(2):200-204. doi: 10.1309/3GEC-PW24-02F6-V8EKColombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173(7):777780. doi: 10.1164/rccm.200510-1620CRColombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173(7):777780. doi: 10.1164/rccm.200510-1620CRWei P, Tao R, Liu Y, Xie H, Jiang S, Yu D, et al. Pulmonary light chain deposition disease: A case series and literature review. Ann Transl Med. 2020;8(9):588. doi: 10.21037/atm-20-2708Wei P, Tao R, Liu Y, Xie H, Jiang S, Yu D, et al. Pulmonary light chain deposition disease: A case series and literature review. Ann Transl Med. 2020;8(9):588. doi: 10.21037/atm-20-2708Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part I. Am J Respir Crit Care Med. 2015;191(12):1354-1366. doi: 10.1164/rccm.201411-2094CIGupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part I. Am J Respir Crit Care Med. 2015;191(12):1354-1366. doi: 10.1164/rccm.201411-2094CIСтепанян ИЭ. Легочный гистиоцитоз из клеток Лангерганса: факты и гипотезы. Практическая пульмонология. 2014;(1): 30-33.Stepanyan IE. Pulmonary Langerhans-cell histiocytosis: Facts and hypotheses. Practical Pulmonology. 2014;(1):30-33 (In Russ.).Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part II. Am J Respir Crit Care Med. 2015;192(1):17-29. doi: 10.1164/rccm.201411-2096CIGupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part II. Am J Respir Crit Care Med. 2015;192(1):17-29. doi: 10.1164/rccm.201411-2096CISeror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome. Ann Rheum Dis. 2007;66(3):351-357. doi: 10.1136/ard.2006.057919Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome. Ann Rheum Dis. 2007;66(3):351-357. doi: 10.1136/ard.2006.057919Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/ European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-748. doi: 10.1164/rccm.201308-1483STTravis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/ European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-748. doi: 10.1164/rccm.201308-1483STDeheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjögren’s syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med. 1996;154(3 Pt 1):794799. doi: 10.1164/ajrccm.154.3.8810621Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjögren’s syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med. 1996;154(3 Pt 1):794799. doi: 10.1164/ajrccm.154.3.8810621Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: Clinical features, associations and prognosis. Eur Respir J. 2006;28(2):364-369. doi: 10.1183/09031936.06.00076705Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: Clinical features, associations and prognosis. Eur Respir J. 2006;28(2):364-369. doi: 10.1183/09031936.06.00076705Lantuejoul S, Moulai N, Quetant S, Brichon PY, Brambilla C, Brambilla E, et al. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma. Eur Respir J. 2007;30(3):589-592. doi: 10.1183/09031936.00136605Lantuejoul S, Moulai N, Quetant S, Brichon PY, Brambilla C, Brambilla E, et al. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma. Eur Respir J. 2007;30(3):589-592. doi: 10.1183/09031936.00136605Lim JK, Lacy MQ, Kurtin PJ, Kyle RA, Gertz MA. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol. 2001;54(8):642-646. doi: 10.1136/jcp.54.8.642Lim JK, Lacy MQ, Kurtin PJ, Kyle RA, Gertz MA. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol. 2001;54(8):642-646. doi: 10.1136/jcp.54.8.642Wieker K, Röcken C, Koenigsmann M, Roessner A, Franke A. Pulmonary low-grade MALT-lymphoma associated with localized pulmonary amyloidosis. A case report. Amyloid. 2002;9(3):190-193. doi: 10.3109/13506120209114821Wieker K, Röcken C, Koenigsmann M, Roessner A, Franke A. Pulmonary low-grade MALT-lymphoma associated with localized pulmonary amyloidosis. A case report. Amyloid. 2002;9(3):190-193. doi: 10.3109/13506120209114821Ikeda SI, Hineno A, Yoshinaga T, Matsuo K, Suga T, Shiina T, et al. Sjögren syndrome-related plasma cell disorder and multifocal nodular AL amyloidosis: Clinical picture and pathological findings. Amyloid. 2019;26(4):225-233. doi: 10.1080/13506129.2019.1660636Ikeda SI, Hineno A, Yoshinaga T, Matsuo K, Suga T, Shiina T, et al. Sjögren syndrome-related plasma cell disorder and multifocal nodular AL amyloidosis: Clinical picture and pathological findings. Amyloid. 2019;26(4):225-233. doi: 10.1080/13506129.2019.1660636Васильев ВИ, Логвиненко ОА, Пробатова НА, Пальшина СГ, Шорникова НС, Ананьева ЛП, и др. Роль биопсии околоушной слюнной железы в ранней диагностике лимфом при болезни Шегрена. Терапевтический архив. 2009;(6):20-27.Vasiliev VI, Logvinenko OA, Probatova NA, Palshina SG, Shornikova NS, Ananieva LP, et al. The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases. Terapevticheskii arkhiv. 2009;(6):20-27 (In Russ.).Gorodetskiy VR, Probatova NA, Radenska-Lopovok SG, Ryzhikova NV, Sidorova YV, Sudarikov AB. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren’s syndrome patients: Case series study and review of the literature. Rheumatol Int. 2020;40(3):499-506. doi: 10.1007/s00296-019-04470-xGorodetskiy VR, Probatova NA, Radenska-Lopovok SG, Ryzhikova NV, Sidorova YV, Sudarikov AB. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren’s syndrome patients: Case series study and review of the literature. Rheumatol Int. 2020;40(3):499-506. doi: 10.1007/s00296-019-04470-xHansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjögren’s syndrome. Mayo Clin Proc. 1989;64(8):920-931. doi: 10.1016/s0025-6196(12)61219-1Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjögren’s syndrome. Mayo Clin Proc. 1989;64(8):920-931. doi: 10.1016/s0025-6196(12)61219-1Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren’s syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65(6):796-803. doi: 10.1136/ard.2005.041186Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren’s syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65(6):796-803. doi: 10.1136/ard.2005.041186Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Okudela K, Yanagawa N, et al. Features of usual interstitial pneumonia in patients with primary Sjögren’s syndrome compared with idiopathic pulmonary fibrosis. Respir Investig. 2014;52(4): 227-235. doi: 10.1016/j.resinv.2014.02.003Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Okudela K, Yanagawa N, et al. Features of usual interstitial pneumonia in patients with primary Sjögren’s syndrome compared with idiopathic pulmonary fibrosis. Respir Investig. 2014;52(4): 227-235. doi: 10.1016/j.resinv.2014.02.003Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sjögren’s syndrome. Nat Rev Rheumatol. 2012;8(7): 399-411. doi: 10.1038/nrrheum.2012.53Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sjögren’s syndrome. Nat Rev Rheumatol. 2012;8(7): 399-411. doi: 10.1038/nrrheum.2012.53Justet A, Ottaviani S, Dieudé P, Taillé C. Tocilizumab for refractory organising pneumonia associated with Sjögren’s disease. BMJ Case Rep. 2015;2015:bcr2014209076. doi: 10.1136/bcr-2014-209076Justet A, Ottaviani S, Dieudé P, Taillé C. Tocilizumab for refractory organising pneumonia associated with Sjögren’s disease. BMJ Case Rep. 2015;2015:bcr2014209076. doi: 10.1136/bcr-2014-209076Ankita G, Shashi D. Pulmonary lymphomatoid granulomatosis – A case report with review of literature. Indian J Surg Oncol. 2016;7(4):484-487. doi: 10.1007/s13193-016-0525-1Ankita G, Shashi D. Pulmonary lymphomatoid granulomatosis – A case report with review of literature. Indian J Surg Oncol. 2016;7(4):484-487. doi: 10.1007/s13193-016-0525-1Weisbrot IM. Lymphomatoid granulomatosis of the lung, associated with a long history of benign lymphoepithelial lesions of the salivary glands and lymphoid interstitial pneumonitis. Report of a case. Am J Clin Pathol. 1976;66(5):792-801. doi: 10.1093/ajcp/66.5.792Weisbrot IM. Lymphomatoid granulomatosis of the lung, associated with a long history of benign lymphoepithelial lesions of the salivary glands and lymphoid interstitial pneumonitis. Report of a case. Am J Clin Pathol. 1976;66(5):792-801. doi: 10.1093/ajcp/66.5.792Волков АВ. Легочная артериальная гипертензия при системных заболеваниях соединительной ткани. Научнопрактическая ревматология. 2015;53(1):69-77. doi: 10.14412/19954484-2015-69-77Volkov AV. Pulmonary arterial hypertension in connective tissue diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(1):69-77 (In Russ.). doi: 10.14412/19954484-2015-69-77Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: Report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86(5):299-315. doi: 10.1097/MD.0b013e3181579781Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: Report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86(5):299-315. doi: 10.1097/MD.0b013e3181579781Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, et al. The prognosis of pulmonary arterial hypertension associated with primary Sjögren’s syndrome: A cohort study. Lupus. 2018;27(7):1072-1080. doi: 10.1177/0961203318756287Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, et al. The prognosis of pulmonary arterial hypertension associated with primary Sjögren’s syndrome: A cohort study. Lupus. 2018;27(7):1072-1080. doi: 10.1177/0961203318756287Wang J, Li M, Wang Q, Zhang X, Qian J, Zhao J, et al. Pulmonary arterial hypertension associated with primary Sjögren’s syndrome: A multicentre cohort study from China. Eur Respir J. 2020;56(5):1902157. doi: 10.1183/13993003.02157-2019Wang J, Li M, Wang Q, Zhang X, Qian J, Zhao J, et al. Pulmonary arterial hypertension associated with primary Sjögren’s syndrome: A multicentre cohort study from China. Eur Respir J. 2020;56(5):1902157. doi: 10.1183/13993003.02157-2019Langenskiöld E, Bonetti A, Fitting JW, Heinzer R, Dudler J, Spertini F, et al. Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide. Respiration. 2012;84(2):144-149. doi: 10.1159/000334947Langenskiöld E, Bonetti A, Fitting JW, Heinzer R, Dudler J, Spertini F, et al. Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide. Respiration. 2012;84(2):144-149. doi: 10.1159/000334947Carmier D, Diot E, Diot P. Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy. Expert Rev Respir Med. 2011;5(1):33-39. doi: 10.1586/ers.10.84Carmier D, Diot E, Diot P. Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy. Expert Rev Respir Med. 2011;5(1):33-39. doi: 10.1586/ers.10.84Трофимов ЕА, Лейнеман ЯА, Мазуров ВИ, Файзенберг РМ, Голимбиевская ТА. Особенности поражения легких у пациентов с системной красной волчанкой. Вестник СевероЗападного государственного медицинского университета им. И.И. Мечникова. 2014;6(1):20-29.Trofimov EA, Leineman IA, Mazurov VI, Faizenberg RM, Golimbievskaya TA. Pulmonary manifestations in patients with systemic lupus erythematosus. Herald of North-Western State Medical University named after I.I. Mechnikov. 2014;6(1):20-29 (In Russ.).Reddy KS, Jha V, Nada R, Kohli HS, Sud K, Gupta KL, et al. Respiratory paralysis in Sjogren syndrome with normal renal function. Na tl Med J India. 2003;16(5):253-234.Reddy KS, Jha V, Nada R, Kohli HS, Sud K, Gupta KL, et al. Respiratory paralysis in Sjogren syndrome with normal renal function. Na tl Med J India. 2003;16(5):253-234.Ohtani H, Imai H, Kodama T, Hamai K, Komatsuda A, Wakui H, et al. Severe hypokalaemia and respiratory arrest due to renal tubular acidosis in a patient with Sjögren syndrome. Nephrol Dial Transplant. 1999;14(9):2201-2203. doi: 10.1093/ndt/14.9.2201Ohtani H, Imai H, Kodama T, Hamai K, Komatsuda A, Wakui H, et al. Severe hypokalaemia and respiratory arrest due to renal tubular acidosis in a patient with Sjögren syndrome. Nephrol Dial Transplant. 1999;14(9):2201-2203. doi: 10.1093/ndt/14.9.2201Poux JM, Peyronnet P, Le Meur Y, Favereau JP, Charmes JP, Leroux-Robert C. Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren’s syndrome. Clin Nephrol. 1992;37(4):189-191.Poux JM, Peyronnet P, Le Meur Y, Favereau JP, Charmes JP, Leroux-Robert C. Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren’s syndrome. Clin Nephrol. 1992;37(4):189-191.Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren’s Syndrome Disease Damage Index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren’s syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007;56(7):2223-2231. doi: 10.1002/art.22658Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren’s Syndrome Disease Damage Index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren’s syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007;56(7):2223-2231. doi: 10.1002/art.22658Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al.; EULAR Sjögren’s Task Force. EULAR Sjogren’s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69(6):1103-1109. doi: 10.1136/ard.2009.110619Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al.; EULAR Sjögren’s Task Force. EULAR Sjogren’s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69(6):1103-1109. doi: 10.1136/ard.2009.110619Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69(8):1670-1678. doi: 10.1002/art.40130Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69(8):1670-1678. doi: 10.1002/art.40130Shi L, Fu Q, Chen N, Liu R, Zheng Y. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren’s syndrome-related interstitial lung disease. Clin Exp Med. 2020;20(3):393-399. doi: 10.1007/s10238-020-00623-6Shi L, Fu Q, Chen N, Liu R, Zheng Y. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren’s syndrome-related interstitial lung disease. Clin Exp Med. 2020;20(3):393-399. doi: 10.1007/s10238-020-00623-6Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, et al. Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases. Respir Med. 2019;159:105811. doi: 10.1016/j.rmed.2019.105811Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, et al. Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases. Respir Med. 2019;159:105811. doi: 10.1016/j.rmed.2019.105811Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, et al.; EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, et al.; EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114Oldham JM, Lee C, Valenzi E, Witt LJ, Adegunsoye A, Hsu S, et al. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016;121:117-122. doi: 10.1016/j.rmed.2016.11.007Oldham JM, Lee C, Valenzi E, Witt LJ, Adegunsoye A, Hsu S, et al. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016;121:117-122. doi: 10.1016/j.rmed.2016.11.007Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2Zhang L, Mo H, Zhu M, Wang L. Effect of cyclophosphamide on cytokines in patients with primary Sjögren’s syndrome-associated interstitial lung disease in South China. Rheumatol Int. 2013;33(6): 1403-1407. doi: 10.1007/s00296-012-2561-7Zhang L, Mo H, Zhu M, Wang L. Effect of cyclophosphamide on cytokines in patients with primary Sjögren’s syndrome-associated interstitial lung disease in South China. Rheumatol Int. 2013;33(6): 1403-1407. doi: 10.1007/s00296-012-2561-7Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013;40(5):640-646. doi: 10.3899/jrheum.121043Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013;40(5):640-646. doi: 10.3899/jrheum.121043Koo SM, Kim SY, Choi SM, Lee HK; Korean Interstitial Lung Diseases Study Group. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 5. Connective tissue disease associated interstitial lung disease. Tuberc Respir Dis (Seoul). 2019;82(4):285-297. doi: 10.4046/trd.2019.0009Koo SM, Kim SY, Choi SM, Lee HK; Korean Interstitial Lung Diseases Study Group. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 5. Connective tissue disease associated interstitial lung disease. Tuberc Respir Dis (Seoul). 2019;82(4):285-297. doi: 10.4046/trd.2019.0009Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21):1968-1977. doi: 10.1056/NEJMoa1113354Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21):1968-1977. doi: 10.1056/NEJMoa1113354Saraux A, Pers JO, Devauchelle-Pensec V. Treatment of primary Sjögren syndrome. Nat Rev Rheumatol. 2016;12(8):456-471. doi: 10.1038/nrrheum.2016.100Saraux A, Pers JO, Devauchelle-Pensec V. Treatment of primary Sjögren syndrome. Nat Rev Rheumatol. 2016;12(8):456-471. doi: 10.1038/nrrheum.2016.100Amlani B, Elsayed G, Barvalia U, Kanne JP, Meyer KC, Sandbo N, et al. Treatment of primary Sjögren’s syndromerelated interstitial lung disease: A retrospective cohort study. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):136-147. doi: 10.36141/svdld.v37i2.8461Amlani B, Elsayed G, Barvalia U, Kanne JP, Meyer KC, Sandbo N, et al. Treatment of primary Sjögren’s syndromerelated interstitial lung disease: A retrospective cohort study. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):136-147. doi: 10.36141/svdld.v37i2.8461Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, et al.; Club Rhumatismes et Inflammations and the French Society of Rheumatology. Efficacy of rituximab in systemic manifestations of primary Sjogren’s syndrome: Results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis. 2013;72(6):1026-1031. doi: 10.1136/annrheumdis-2012-202293Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, et al.; Club Rhumatismes et Inflammations and the French Society of Rheumatology. Efficacy of rituximab in systemic manifestations of primary Sjogren’s syndrome: Results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis. 2013;72(6):1026-1031. doi: 10.1136/annrheumdis-2012-202293Chen MH, Chen CK, Chou HP, Chen MH, Tsai CY, Chang DM. Rituximab therapy in primary Sjögren’s syndrome with interstitial lung disease: A retrospective cohort study. Clin Exp Rheumatol. 2016;34(6):1077-1084.Chen MH, Chen CK, Chou HP, Chen MH, Tsai CY, Chang DM. Rituximab therapy in primary Sjögren’s syndrome with interstitial lung disease: A retrospective cohort study. Clin Exp Rheumatol. 2016;34(6):1077-1084.Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, et al. Treatment of primary Sjögren syndrome with rituximab: A randomized trial. Ann Intern Med. 2014;160(4):233-242. doi: 10.7326/M13-1085Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, et al. Treatment of primary Sjögren syndrome with rituximab: A randomized trial. Ann Intern Med. 2014;160(4):233-242. doi: 10.7326/M13-1085Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, et al.; INBUILD trial investigators. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: A randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8(5):453-460. doi: 10.1016/S22132600(20)30036-9Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, et al.; INBUILD trial investigators. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: A randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8(5):453-460. doi: 10.1016/S22132600(20)30036-9Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al.; INBUILD Trial Investigators. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718-1727. doi: 10.1056/NEJMoa1908681Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al.; INBUILD Trial Investigators. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718-1727. doi: 10.1056/NEJMoa1908681Enomoto Y, Nakamura Y, Colby TV, Inui N, Suda T. Pirfenidone for primary Sjögren’s syndrome-related fibrotic interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):91-96. doi: 10.36141/svdld.v34i1.5091Enomoto Y, Nakamura Y, Colby TV, Inui N, Suda T. Pirfenidone for primary Sjögren’s syndrome-related fibrotic interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):91-96. doi: 10.36141/svdld.v34i1.5091Vacchi C, Sebastiani M, Cassone G, Cerri S, Della Casa G, Salvarani C, et al. Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review. J Clin Med. 2020;9(2):407. doi: 10.3390/jcm9020407Vacchi C, Sebastiani M, Cassone G, Cerri S, Della Casa G, Salvarani C, et al. Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review. J Clin Med. 2020;9(2):407. doi: 10.3390/jcm9020407Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: Assessment with high reso lution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282-289. doi: 10.1097/00005382-200110000-00009Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: Assessment with high reso lution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282-289. doi: 10.1097/00005382-200110000-00009Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, et al. Sjögren’s syndrome: State of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000789. doi: 10.1136/rmdopen-2018-000789Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, et al. Sjögren’s syndrome: State of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000789. doi: 10.1136/rmdopen-2018-000789

The authors declare that there are no conflicts of interest present.